Avodart was GSK's second biggest earner in 12/13...if ever there was a problem with the drug, we would know by now...I just don't buy the argument that the physiology of the population differs widely across age ranges. No pictures unfortunately, as I never intended to measure my progress...just hope I maintained. More @Wikipedia
Hover over any link to get a description of the article. Please note that search keywords are sometimes hidden within the full article and don't appear in the description or title.